“Patients are looking for the next ‘best thing.’ And I think that’s where the real opportunity is: where does technology coincide with a patient?”

As the Chief Commercial Officer at Revance, Erica Jordan spearheads the development and execution of growth strategies for the aesthetics and therapeutics markets. Leaning on over 20 years of experience in med-tech, biotech, and dental, she has worked for a number of leading companies, including GE, Siemens, and Philips.

With the stated goal of setting a “new standard in healthcare by elevating patient and physician experiences,” Revance boasts an impressive lineup of aesthetic and therapeutic offerings. Notable among these are the RHA Collection of dermal fillers, designed to adapt to dynamic facial movements for natural-looking results, and Daxxify, a long-lasting/fast-acting neurotoxin for smoothing frown lines that is powered by a novel peptide. What’s more, Daxxify was recently FDA-approved for the treatment of cervical dystonia in adults.

Tune in for a sneak peek at what’s next in the biotech pipeline at this up-and-coming aesthetic player on the latest episode of The Technology of Beauty.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/

The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/

Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/